Discover Great Companies Discover Great Clients
Popularity  4.6万   |   Followers  35   |   Likes  14   |   Feedback  39 Claim this company

Leading enterprise of the National Biological Industry Base

No.169 Chongqing Popularity Ranking No.8 Nan'an District No.1 Nutrition Food No.1 Health Products No.2 Kang Zhong Liu Yao No.2 Health Products No.3 Chemistry Pharmaceuticals No.4 Chinese Patent Medicines No.5 APIs No.5 Pharmaceutical APIs No.6 Raw Materials No.8 Gong Cheng Yan Jiu Center No.8 Medical Devices No.8 Pharmaceutical R&D 名牌产品 企业技术中心 AAA级信用企业 创新型企业 市级重点新产品 市级高新技术企业
More

Company Overview

  • Nature: Listed Company Size: 1000-4999 employees Founded: 27年
  • Industry: Pharmaceutical/Bioengineering
  • Full name: Chongqing Lummy Pharmaceutical Co., Ltd.。

Development Stage

  • Stage: IPO上市, 创业板, 深交所。
  • Ranking: Ranked #169 in Chongqing by popularity Ranked #1 in Chongqing Nutrition Food Company by popularity Ranked #1 in Chongqing Health Products Company by popularity Ranked #2 in Chongqing Kang Zhong Liu Yao Company by popularity Ranked #2 in Chongqing Health Products Company by popularity
  • Honors: 名牌产品 企业技术中心 According to algorithm
  • News: 2025-06-26:莱美药业:仿制药玛巴洛沙韦片获得伦理批件。
  • Salary: 71.8% of positions earn 4.5-15K, In 2026 vs last yeargrew by 11%.。Master's salary: ¥26.7K.
  • R&D: "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 14.1%, "Medical & Health/Beauty & Healthcare": 11.1%, "Agriculture, Forestry and Fishery": 9.1%。
  • Recruiting: In 2026 vs 2025grew by 3%. Demand for highly educated talent: Master's: 2.
  • Requirement: Education: 本科 leads with 48.5%. Experience: 不限 leads with 55.6%.
  • Region: Distributed across 4 regions, 重庆: 55.6%, 济南: 5.1%, 洛阳: 5.1%, 成都: 5.1%.

About the Company

[Summary] Leading enterprise of the National Biological Industry Base

(1) Chongqing Lummy Pharmaceutical Co., Ltd. was listed on the ChiNext Board of the Shenzhen Stock Exchange on October 30, 2009 (stock code: 300006). It is a high-tech, group-managed pharmaceutical enterprise integrating research, production, and sales. Its product types include chemical drugs, active pharmaceutical ingredients, biological preparations, traditional Chinese patent medicines, and health products. It has several subsidiaries including Chayuan Formulation Plant, Changshou API Plant, Kangyuan Pharmaceutical, Jinxing Pharmaceutical, and Sichuan Hezheng Pharmaceutical, with approximately 2,000 employees currently.
(2) Overall strength of the company: From 2012 to 2015, it was successively rated as "*Innovative (Pilot) Enterprise", "China's Best Industrial Enterprise in Pharmaceutical R&D Product Line", "Chongqing Municipal Technology Innovation Demonstration Enterprise", and "Chongqing Municipal Intellectual Property Pilot Unit".
(3) R&D and innovation capability of the company: We focus on research and development, and innovative R&D is the company's core competitiveness. The company currently has an R&D team of about 130 people and possesses two R&D platforms: "Chongqing Lummy Pharmaceutical Technology Center" and "Lummy-Sichuan University Joint Laboratory". It also has a "Municipal-level Enterprise Technology Center" in Chongqing and a "Chongqing Drug Quality Control Engineering Technology Research Center" jointly established with the US-listed company Cell Genesys. After more than 10 years of development, in terms of scientific research and innovation, it has formed an independent innovation R&D platform represented by nano-drug technologies for lymphatic tracing, lymphatic-targeted chemotherapy, and tumor-targeted chemotherapy, a scientific research transformation technology platform represented by micron and nano dispersion technologies and sterile API preparation technologies, and a new drug generic platform represented by anti-infective drugs and specialty drugs. It has successfully applied for more than 200 patents, and its new drug applications rank among the top in Chongqing and even nationwide.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Lummy Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 创业板
  • Deal: 深交所

Lummy Pharmaceutical How Fast Is Hiring Growing? (33 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 5%
  • 2024: Flat 0%-
  • 2023: Up 71%
  • 2022: Down 65%
Lummy Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Lummy Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Part-time 8 Master's 2
Note: How fast is hiring at Chongqing Lummy Pharmaceutical Co., Ltd. growing? Lummy Pharmaceutical2026: 65 openings (up 3%), 2025: 63 openings (up 5%), 2024: 60 openings (flat), 2023: 60 openings (up 71%), 2022: 35 openings (down 65%), 2021: 99 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Lummy Pharmaceutical Master's Degree Job Demand Analysis

(More)
Lummy Pharmaceutical Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Chongqing Lummy Pharmaceutical Co., Ltd. growing? Lummy PharmaceuticalMaster's recruitment over the years: 2025: 3 openings (up 5%), 2023: 11 openings (up 71%), 2021: 1 openings.

Lummy Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Chongqing Lummy Pharmaceutical Co., Ltd.? Based on an analysis of Lummy Pharmaceutical's job postings over the past year, "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 14.1%, "Medical & Health/Beauty & Healthcare": 11.1%, "Agriculture, Forestry and Fishery": 9.1%, "Mechanical/Instrumentation": 2%, "Other (R&D and Technical)": 1%. For reference only.

Lummy Pharmaceutical — What Are the Salaries Like? (99 records)

Manage
Lummy Pharmaceutical Salary Overview
salary range: 3K - 50K, 71.8% of roles pay ¥4.5-15K
Note: salary statistics are based on 99 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Chongqing Lummy Pharmaceutical Co., Ltd.?Lummy Pharmaceutical71.8% of positions earn 4.5-15K, Undergraduate salary: ¥。Chongqing salary ranking top 40,销售类 average salary ¥10.2K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Lummy Pharmaceutical

(More)
Are salaries high at Chongqing Lummy Pharmaceutical Co., Ltd.? We provide: Leasing Manager, Finance Specialist, Promotion Specialist, Accountant, QA, QC, Orthopedics, Business Development, BP, Administrative Specialist, Business Development, Securities Specialist, Supply Chain, Security Guard, Analyst, Vice President, Regional Manager, Medical Manager, Synthesis Supervisor, General Ledger Accountant. Click to view detailed salary analysis by job.

Job Category

  • 销售类
    40.4% of total 40.4%
  • 市场/公关/媒介类
    30.3% of total 30.3%
  • 经营管理类
    23.2% of total 23.2%
  • 财务/审计/统计类
    18.2% of total 18.2%

Education

  • 本科
    48.5% of total 48.5%
  • 大专
    37.4% of total 37.4%
  • 硕士
    6.1% of total 6.1%
  • 高中
    4% of total 4%

Experience

  • 不限
    55.6% of total 55.6%
  • 5-10年
    16.2% of total 16.2%
  • 1-3年
    14.1% of total 14.1%
  • 3-5年
    14.1% of total 14.1%
View Detailed Analysis

What does Chongqing Lummy Pharmaceutical Co., Ltd. require? Who is Lummy Pharmaceutical hiring? Lummy Pharmaceutical recruitment: 销售类占比最多占40.4%,其次是市场/公关/媒介类占30.3%. What education can get in at Lummy Pharmaceutical? 本科占比最多占48.5%,其次是大专占37.4%. High education required at Lummy Pharmaceutical? 硕士占6.1%. Work experience required at Lummy Pharmaceutical? 不限占比最多占55.6%,其次是5-10年占16.2%. Where are the job locations at Lummy Pharmaceutical? 重庆占比最多占55.6%,其次是济南占5.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 105,591.1205万(元)
Legal Representative: 梁建生
Date Established:
Credit Code: 915000006219193432
Registered Address: 重庆市南岸区玉马路99号

Partners & Suppliers

公司原料药供应商,2021年度前五大供应商之一 Source
合作客户 原料药/中间体
莱美药业向梧州制药销售氨甲环酸氯化钠注射液等化学药产品 Source
合作客户 化学药销售
莱美药业向梧州制药采购中药材或中成药产品 Source
供应商 中药材/中成药采购
春光九汇向莱美药业供应中药配方颗粒产品,莱美负责部分区域销售 Source
供应商 中药配方颗粒
成都先导利用其DNA编码化合物库技术为莱美药业筛选先导化合物 Source
供应商 新药研发服务(DNA编码化合物库筛选)

People who follow Lummy Pharmaceutical also follow

Lummy Pharmaceutical Competitors (Similar Companies)

制药/药业 医药 新药研发 原料药
“For many consecutive years, it has maintained a leading position in do”
“Virtue over the world, medicine benefits all”
“To provide patients with trustworthy and affordable innovative biologi”
“The company is a group pharmaceutical enterprise integrating R&D, prod”
“Serving human pharmaceutical and health undertakings”
“Key pharmaceutical enterprise in Chongqing”
医药 药物研发 生物医药 CRO
体外诊断试剂 诊断试剂 试剂 抗体
“Drafting unit of national standards and industry standards in the fiel”
医药营销 药物研发 生物医药 大健康
医药 CRO 临床试验设计 药物研发
制药/药业 医药 药物研发 生物制品
制药/药业 医药 新药研发 原料药
“Primarily engaged in the research and development, production, and sal”

Discover Great Companies, Discover Great Clients

重庆公司名录 重庆“Nan'an District”公司名录 重庆“制药/药业”公司名录 重庆“医药”公司名录 重庆“抗肿瘤药”公司名录 重庆“药物研发”公司名录 重庆“生物医药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates